Business Segments CSPC Pharmaceutical Group Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 03:08:04 2026-02-06 am EST			5-day change	1st Jan Change
9.660 ^HKD	-0.82%		+0.62%	+14.59%

Feb. 03	Asian Stock Markets Rally on Renewed AI Fervor; Tokyo, Seoul Strike Zeniths Again	MT
Feb. 02	CSPC Pharma's Clevidipine Injection Receives China Registration Approval	MT

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (HKD)

Fiscal Period: December	2020 (CNY)	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)
Pharmaceutical Products
Finished Drugs	20.4B	22.68B	24.52B	25.64B	23.74B
D&A	547M	610M	751M	802M	1.01B
Operating Income	4.81B	5.22B	6.07B	6.7B	4.83B
Bulk Products - Antibiotics	-	-	-	2.01B	1.77B
D&A	-	-	-	76.62M	81.58M
Operating Income	-	-	-	154M	299M
Caffeine and Others	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Raw Material Product - Antibiotics and Others	1.49B	1.85B	2.21B	-	-
D&A	94.84M	92.8M	99.93M	-	-
Operating Income	120M	143M	190M	-	-
Vitamins and Nutritional Supplements
Bulk Products - Vitamin C	1.87B	2.16B	2.53B	1.94B	2.03B
D&A	84.97M	86.33M	123M	155M	169M
Operating Income	333M	742M	443M	4.95M	211M
Functional Food and Others	1.32B	1.39B	2.05B	2.47B	1.86B
D&A	66.92M	66.68M	64.03M	74.11M	65.35M
Operating Income	275M	316M	572M	562M	305M
Corporate	-	-	-	-	-
Operating Income	-	-	-	-	-
Eliminations	-138M	-216M	-375M	-612M	-395M
Operating Income	-	-	-	-	-
Operating Income	-	-	-	-	-
D&A	15.25M	9.78M	9.71M	9.86M	9.91M
Inorganic Dyes and Pigments
Others	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-

Geographical breakdown of sales (HKD)

Fiscal Period: December	2020 (CNY)	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)
Mainland China	21.62B	24.29B	26.14B	27.18B	25.11B
Total Assets	14.15B	14.41B	17.81B	19.54B	22.5B
Europe	987M	700M	1.27B	1.28B	1.31B
Other Asian Regions	872M	1.47B	1.74B	1.58B	1.18B
North America	-	-	-	882M	853M
Others	215M	244M	284M	525M	554M
Americas	-	-	1.51B	-	-
United States of America (“USA”)	1.25B	1.16B	-	-	-